|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Revenue: | |||||
| Collaboration and license revenue | |||||
| Operating expenses: | |||||
| Research and development (includes $1,322 and $1,005 for the years ended December 31, 2025 and 2024, respectively, attributable to related parties) | |||||
| General and administrative | |||||
| Total operating expenses | |||||
| Loss from operations | |||||
| Other income (expense): | |||||
| Interest income | |||||
| Other expense, net | |||||
| Total other income, net | |||||
| Net loss | |||||
| Net loss per share, basic | |||||
| Net loss per share, diluted | |||||
| Weighted-average shares outstanding used in computing net loss per share, basic | |||||
| Weighted-average shares outstanding used in computing net loss per share, diluted | |||||
Loading...
